List of SBIR/STTR awards granted to Rise Therapeutics, LLC
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Rise Therapeutics, LLC in February, 2021 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI157031-01 | Phase II | 1,000,000 | February 23, 2021 | |||||||
A SBIR Phase II contract was awarded to Rise Therapeutics, LLC in May, 2020 for $892,209.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DK117726-02A1 | Phase II | 892,209 | May 20, 2020 | |||||||
A SBIR Phase I contract was awarded to Rise Therapeutics, LLC in April, 2021 for $386,860.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA261509-01 | Phase I | 386,860 | April 1, 2021 | |||||||
A SBIR Phase II contract was awarded to Rise Therapeutics, LLC in July, 2020 for $957,796.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI152670-01A1 | Phase II | 957,796 | July 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Rise Therapeutics, LLC in February, 2019 for $299,931.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI142975-01A1 | Phase I | 299,931 | February 15, 2019 | |||||||
A SBIR Phase II contract was awarded to Rise Therapeutics, LLC in July, 2019 for $956,644.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DE026379-02 | Phase II | 956,644 | July 10, 2019 | |||||||
A SBIR Phase II contract was awarded to Rise Therapeutics, LLC in May, 2021 for $998,658.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1SB1DE030833-01A1 | Phase II | 998,658 | May 12, 2021 | |||||||
A SBIR Phase I contract was awarded to Rise Therapeutics, LLC in July, 2018 for $480,497.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK117726-01A1 | Phase I | 480,497 | July 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Rise Therapeutics, LLC in February, 2018 for $299,953.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AI138681-01 | Phase I | 299,953 | February 6, 2018 | |||||||
A SBIR Phase I contract was awarded to Rise Therapeutics, LLC in July, 2022 for $360,624.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK133061-01A1 | Phase I | 360,624 | July 5, 2022 | |||||||
A SBIR Phase II contract was awarded to Rise Therapeutics, LLC in July, 2022 for $1,099,436.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK134274-01 | Phase II | 1,099,436 | July 1, 2022 | |||||||
A SBIR Phase I contract was awarded to Rise Therapeutics, LLC in July, 2022 for $282,514.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43TR004300-01 | Phase I | 282,514 | July 15, 2022 | |||||||
A SBIR Phase II contract was awarded to Rise Therapeutics, LLC in July, 2022 for $1,049,717.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA261509-02 | Phase II | 1,049,717 | July 1, 2022 | |||||||
A SBIR Phase II contract was awarded to Rise Therapeutics, LLC in August, 2023 for $1,001,952.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44DK133061-02 | Phase II | 1,001,952 | August 1, 2023 | |||||||
A SBIR Phase II contract was awarded to Rise Therapeutics, LLC in September, 2023 for $1,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DK137649-01 | Phase II | 1,000,000 | September 1, 2023 | |||||||
A SBIR Phase II contract was awarded to Rise Therapeutics, LLC in January, 2023 for $1,026,596.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI174332-01 | Phase II | 1,026,596 | January 17, 2023 | |||||||
A SBIR Phase I contract was awarded to Rise Therapeutics, LLC in April, 2023 for $306,499.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AI174844-01A1 | Phase I | 306,499 | April 24, 2023 | |||||||
A SBIR Phase I contract was awarded to Rise Therapeutics, LLC in September, 2023 for $494,488.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44AG084484-01 | Phase I | 494,488 | September 4, 2023 |
